Cerus
CERS
#7606
Rank
$0.38 B
Marketcap
$2.00
Share price
-3.62%
Change (1 day)
11.45%
Change (1 year)

Cerus (CERS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.15 Billion USD

According to Cerus's latest financial reports the company's total liabilities are $0.15 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerus - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.14 B-0.2%
2023-12-31$0.14 B-3.49%
2022-12-31$0.14 B-1.55%
2021-12-31$0.15 B29.14%
2020-12-31$0.11 B8.41%
2019-12-31$0.10 B37.42%
2018-12-31$78.94 M33.11%
2017-12-31$59.3 M29.8%
2016-12-31$45.68 M2.36%
2015-12-31$44.63 M10.89%
2014-12-31$40.25 M-0.82%
2013-12-31$40.58 M36.14%
2012-12-31$29.81 M10.19%
2011-12-31$27.05 M10.72%
2010-12-31$24.43 M87.34%
2009-12-31$13.04 M-0.14%
2008-12-31$13.06 M-28.71%
2007-12-31$18.32 M23.41%
2006-12-31$14.84 M-36.51%
2005-12-31$23.38 M-70.98%
2004-12-31$80.58 M22.22%
2003-12-31$65.93 M292.98%
2002-12-31$16.77 M-21.98%
2001-12-31$21.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Haemonetics
HAE
$1.59 B 941.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$2.6 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
$19.07 B 12,370.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
$3.26 M-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA